Laboratoire L. Lafon
Records under this name other than patents Laboratoire L. Lafon holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,335,337 | Substituted piperazinones and their therapeutic uses Formerly held Term ended Term ended Jan 9, 2021 · USPTO record | Term ended | Term ended Jan 9, 2021 | USPTO record |
| US 6,462,089 | Method for correcting the vigilance disorders associated with myopathies Formerly held Term ended Term ended Jun 29, 2020 · USPTO record | Term ended | Term ended Jun 29, 2020 | USPTO record |
| US 6,166,035 | 1,4-dihydropyridine derivatives and their use in therapy Formerly held Term ended Term ended Jul 8, 2019 · USPTO record | Term ended | Term ended Jul 8, 2019 | USPTO record |
| US 6,515,127 | Method for preparing quinoline-5,8-diones Lapsed on the fee record Ended Feb 4, 2015 · USPTO record | Lapsed on the fee record | Ended Feb 4, 2015 | USPTO record |
| US 6,333,338 | Bispiperidines as antithrombotic agents Lapsed on the fee record Ended Dec 25, 2013 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2013 | USPTO record |
| US 6,538,039 | Pharmaceutical dosage form for transdermal administration Lapsed on the fee record Ended Mar 25, 2011 · USPTO record | Lapsed on the fee record | Ended Mar 25, 2011 | USPTO record |
| US 7,033,606 | Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis Lapsed on the fee record Ended Apr 25, 2010 · USPTO record | Lapsed on the fee record | Ended Apr 25, 2010 | USPTO record |
| US 6,344,456 | Piperazinone derivatives and their uses Lapsed on the fee record Ended Feb 5, 2010 · USPTO record | Lapsed on the fee record | Ended Feb 5, 2010 | USPTO record |
| US 6,325,990 | Film forming composition for spraying on the skin Lapsed on the fee record Ended Dec 4, 2009 · USPTO record | Lapsed on the fee record | Ended Dec 4, 2009 | USPTO record |
| US 6,268,397 | Use of (.alpha.-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reuptake and new compounds for this use Lapsed on the fee record Ended Jul 31, 2009 · USPTO record | Lapsed on the fee record | Ended Jul 31, 2009 | USPTO record |